The research gathered perspectives from patients and physicians, and made recommendations to help address the issues related to underrepresentation.
An abstract presented at the American College of Rheumatology (ACR) Convergence 2021 aimed to identify barriers in engaging diverse racial and ethnic patient populations in lupus clinical trials and explore potential approaches to ensure equitable representation.
You can access the story featured in “Rheumatology Advisor” here.